The B cell receptor (BCR) regulates B cell development and function through immunoglobulin (Ig) ␣ and Ig ␤ , a pair of membrane-bound Ig superfamily proteins, each of which contains a single cytoplasmic immunoreceptor tyrosine activation motif (ITAM). To determine the function of Ig ␤ , we produced mice that carry a deletion of the cytoplasmic domain of Ig ␤ (Ig ␤⌬ C mice) and compared them to mice that carry a similar mutation in Ig ␣ (MB1 ⌬ C, herein referred to as Ig ␣⌬ C mice). Ig ␤⌬ C mice differ from Ig ␣⌬ C mice in that they show little impairment in early B cell development and they produce immature B cells that respond normally to BCR cross-linking as determined by Ca 2 ϩ flux. However, Ig ␤⌬ C B cells are arrested at the immature stage of B cell development in the bone marrow and die by apoptosis. We conclude that the cytoplasmic domain Ig ␤ is required for B cell development beyond the immature B cell stage and that Ig ␣ and Ig ␤ have distinct biologic activities in vivo.
Introduction
Signals from the B cell receptor (BCR) 1 regulate many of the essential physiologic activities in the B cell pathway. These include several different transitions in B cell development, allelic exclusion, central and peripheral tolerance, as well as B cell survival and response to antigen (1) . All of these functions appear to be induced by signals emanating from the Ig-associated heterodimer of Ig ␣ and Ig ␤ (2-4). Signals initiated by ligand binding to membrane (m)IgM are communicated to the Ig ␣ -Ig ␤ transducer through a noncovalent interaction that involves polar residues in the plane of the cell membrane (5) (6) (7) . Mutations that disrupt these polar residues interfere with signal transduction and early B cell development (5) (6) (7) (8) .
The discovery that the BCR signal transducer is a heterodimer led to the proposal that the Ig ␣ and Ig ␤ subunits might have distinct biological functions. Biochemical studies showing that the cytoplasmic tails of Ig ␣ and Ig ␤ bind to different sets of cellular kinases (9) and transfection experiments showing differences in the signaling activities of Ig ␣ and Ig ␤ cytoplasmic domains support this idea (6, 7, (10) (11) (12) (13) (14) . However, experiments performed in mice have failed to show any differences in the biologic activities of Ig ␣ and Ig ␤ . Similarly, there are no known qualitative differences in the activities of any of the immunoreceptor tyrosine activation motifs (ITAMs) in the CD3 chains of the TCR (15) (16) (17) (18) (19) (20) (21) .
Three approaches have been used to determine the function of Ig ␣ and Ig ␤ in vivo: transgenic expression of chimeric proteins (8, 22, 23) , Ig ␤ gene deletion (24) , and Ig ␣ cytoplasmic tail mutation (25) . Transgenic experiments showed that the cytoplasmic domain of either Ig ␣ or Ig ␤ was sufficient to activate allelic exclusion and pre-B cell development and led to the conclusion that Ig ␣ and Ig ␤ are redundant in early B cell development (8, 22, 23) . Deletion of Ig ␤ resulted in B cells that failed to assemble a BCR and
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Ig ␤ Cytoplasmic Tail Truncation were arrested at the pre-BI cell stage, suggesting that BCR assembly is essential for B cell development (24) . Deletion of 40 of the 61 cytoplasmic amino acids of Ig ␣ , including both ITAM tyrosines (Ig ␣⌬ C [25] ), produced B cells that assembled a mutant BCR composed of mIg and an Ig ␣ -Ig ␤ heterodimer with a truncated Ig ␣ tail. In agreement with the transgenic experiments, the single Ig ␤ cytoplasmic domain in the Ig ␣⌬ C BCR was enough to induce pre-B cell development and allelic exclusion (8, 25) . However, the number of pre-B cells in Ig ␣⌬ C mice was reduced by 50%, immature B cells were reduced by 80%, and the number of mature B cells in spleen was only 1% of control. Thus, a BCR with only an Ig ␤ cytoplasmic domain was unable to support later stages of B cell development. Furthermore, increased tyrosine phosphorylation in Ig ␣⌬ C B cells and increased calcium flux in response to receptor cross-linking suggested a unique negative regulatory role for the Ig ␣ cytoplasmic domain (26, 27) .
To compare the biologic function of Ig ␣ and Ig ␤ directly, we produced mice that carry a targeted deletion of the cytoplasmic domain of Ig ␤ .
Materials and Methods
Mice. Ig ␤⌬ C mice were created by gene targeting in 129/Sv embryonic stem cells (24) . To shorten the cytoplasmic tail of Ig ␤ by 45 amino acids and delete the ITAM, the stop codon TGA was introduced by PCR at amino acid 184 (4). A unique HindIII site was placed into the targeting vector between the exons as indicated (see Fig. 1 A) . A lox-P-flanked neomycin resistance gene was inserted between two XbaI sites, and sequence coding for diphtheria toxin (DTA [28] ) was added to the 3 Ј end of the targeted locus at the XhoI site (see Fig. 1 A) . Homologous recombination was confirmed by Southern blotting after digestion with HindIII (see Fig. 1 B) . The rate of homologous recombination was 1:80. The genomic fragment used as a probe for Southern blotting was amplified by PCR using the specific primers GGAT-TCGAATGGTGAATGTTGG and AGGCTCTAGCTCAGT-GAAGGGAG. PCR conditions were: 94 Њ C for 5 min, and 30 cycles of 94 Њ C for 30 s, 48 Њ C for 45 s, and 72 Њ C for 1 min, followed by extension at 72 Њ C for 7 min. To delete the neomycin gene, mice carrying the targeted Ig ␤ gene were bred to C57BL/6 Cre transgenic mice (29) . Deletion of the neomycin gene was confirmed by PCR using neomycin-specific primers ATGAT-TGAACAAGATGGATTGCAC and TCGTCCAGATCATC-CTGATCGAC. PCR conditions were: 94 Њ C for 3 min, and 30 cycles of 94 Њ C for 1 min, 58 Њ C for 45 s, and 72 Њ C for 1 min, followed by extension at 72 Њ C for 7 min. Heterozygous Ig ␤⌬ C mice were backcrossed to C57BL/6 mice for three generations before intercrossing to produce homozygous Ig ␤⌬ C mice. All mice were bred and maintained under specific pathogen-free conditions.
Ig ␣⌬ C mice (25) were crossed with Ig ␤⌬ C mice to create Ig-␣⌬ C/Ig ␤⌬ C mixed heterozygous and homozygous mice (25) . Ig ␤⌬ C mice were also bred to C57BL/6 Ig HEL Ig transgenic mice (30) .
Flow Cytometry. Single cell suspensions from bone marrow, spleen, and peritoneal cavity were stained with FITC, PE, allophycocyanin, and biotin-conjugated monoclonal antibodies visualized with streptavidin red 613 (GIBCO BRL). Monoclonal antibodies were anti-CD43, anti-IgM, anti-B220, anti-CD25, antiIgD, anti-CD19, anti-IgM a , anti-IgM b (BD PharMingen), biotin anti-Ig ␤ (a gift from H. Karasuyama, The Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan), and anti-493 (a gift from A. Rolink, Basel Institute for Medical Science, Basel, Switzerland). For intracellular Ig staining, cells were first surface stained with anti-B220-allophycocyanin, anti-CD25-PE, and/or anti-IgM-PE, and anti-CD43-biotin, permeabilized with Intraprep permeabilization kit (Immunotech), and incubated with Fab Ј fragments of FITC-goat anti-mouse IgM. Data were collected on a FACSCalibur™ and analyzed using CELLQuest™ software (Becton Dickinson).
Cell Cycle Analysis. Bone marrow cells were incubated at 37 Њ C for 40 min with Hoechst 33342 (Molecular Probes) diluted 1:1,000, then stained for cell surface markers with anti-B220, anti-IgM, anti-CD43, and anti-CD25. Data were collected on a FACS Vantage™ and analyzed with CELLQuest™ software (Becton Dickinson).
Ca 2 ϩ Flux. Bone marrow cells were adjusted to 5 ϫ 10 6 /ml in PBS plus 1% FCS plus 1 mM CaCl 2 plus 1 mM MgCl 2 (loading buffer), and incubated with 1.5 M Indo-1-AM (Molecular Probes) for 30 min at 37 Њ C. Cells were stained with PE-anti-B220 and Fab Ј FITC-goat anti-mouse IgM (Jackson ImmunoResearch Laboratories). Calcium flux was measured by fluorescence emission ratios of Indo-1-AM on a dual laser FACS Vantage™ (Becton Dickinson) at 395/510 nm on B220 low IgM ϩ cells. Data were acquired for 60 s before BCR cross-linking with F(ab Ј ) 2 goat anti-mouse IgM (Southern Biotechnology Associates, Inc.) at 10 or 20 g/ml.
B Cell Cultures. Bone marrow B cells from mutant or wildtype mice were enriched by positive selection using MACS mouse CD19 microbeads (Miltenyi Biotech) and stained with FabЈ anti-IgM, and monoclonal anti-CD25, anti-CD43, and anti-B220. B cells were then sorted into B220 ϩ CD43 Ϫ IgM low immature B cells and cocultured at 10 6 /ml with irradiated S17 stromal cells in RPMI 1640 supplemented with 10% FCS and 10 ng/ml IL-7 (BD PharMingen [31] ). B cell viability was assessed on days 0 and 1 by flow cytometry using PE-annexin V (BD PharMingen) and propidium iodide staining.
Immunization. 6-8-wk-old Ig␤⌬C and C57BL/6 mice were immunized intraperitoneally with either 50 g alum-precipitated 4-hydroxy-3-nitrophenylacetyl coupled to chicken gamma globulin (NP-CGG) or 50 g NP-Ficoll in PBS. Blood was collected from the tail vein of each mouse before immunization and at days 7, 14, 21, and 28 after immunization. NP-specific IgM and IgG levels were measured by ELISA using plates coated with NP 16 BSA (5 g/ml) and developed with anti-IgM coupled to horseradish peroxidase or anti-IgG coupled to horseradish peroxidase (Southern Biotechnology Associates, Inc. [32] ). Immunoabsorbance was read at 415 nm and titers were calculated relative to control sera from unimmunized mice. Four mice were used in each group.
Results

B Cell Development in Ig␤⌬C
Mice. Gene targeting was used to introduce a stop codon at position 184 in Ig␤ (Fig.  1 A) . The mutant gene directs the expression of a truncated Ig␤ protein that resembles mIg in having only three charged cytoplasmic anchor amino acids (DKD).
B cell development in Ig␤⌬C mice was analyzed by multiparameter flow cytometry. When compared with wildtype controls, Ig␣⌬C and Ig␤⌬C mice showed an increase in the number of IgM Ϫ B220 ϩ CD43 ϩ CD25 Ϫ pro-B cells (25; Table I and Fig. 1 C) . Both strains also showed smaller numbers of IgM Ϫ B220 ϩ CD43 Ϫ CD25 ϩ pre-BII cells (fraction CЈ/D) than wild-type, although the 25% decrease found in Ig␤⌬C mice was less substantial than the 50% decrease found in Ig␣⌬C mice (25; Table I and Fig. 1 C) .
After H chain expression, pre-BI cells become large dividing pre-BII cells (fraction CЈ [33] [34] [35] [36] ). To determine whether the single Ig␣ cytoplasmic domain in the Ig␤⌬C BCR is sufficient to trigger normal pre-BII cell division, we measured the DNA content of these cells. We found that the cell cycle distribution of large pre-BII cells in Ig-␤⌬C mice was similar to that of control mice (Fig. 1 C and  Table I ). Thus, the single cytoplasmic tail of Ig␣ in the Ig-␤⌬C BCR is sufficient to trigger pre-BII cell (fraction CЈ) proliferation.
After mIg triggered proliferative expansion, B cells rearrange Ig L chain genes, express surface IgM, lose CD25 expression, and then express IgD (37) . Few B cells in Ig-␣⌬C mice progress to the B220 ϩ CD43 Ϫ IgM ϩ IgD Ϫ "immature" B cell stage (fraction E) (25; To determine whether this failure to mature is due to low levels of surface Ig␣-Ig␤ expression, we stained developing B cells with anti-Ig␤ monoclonal antibody (38) . We found that for any given level of surface IgM expression, the level of cell surface Ig␤ on B220 ϩ IgM ϩ immature B cells was similar in Ig␤⌬C B cells and controls (Fig. 1 C) . Table I ).
To determine whether arrest at the CD25 ϩ IgM ϩ IgD Ϫ immature B cell stage is associated with increased cell death, we established in vitro bone marrow cultures (31) . Immature B cells were purified by cell sorting using a FabЈ anti-IgM to avoid receptor cross-linking. Cell death was measured by propidium iodide exclusion and annexin V staining (Fig. 2) . Annexin V staining varies between different stages of B cell development and is therefore unreliable when comparing B cells in different stages (39) . However, annexin is a reliable marker for apoptosis when comparing cells at similar stages Data represent the mean from four mice Ϯ SD. in development (39 (42) and displayed a mature phenotype (data not shown). We also examined splenic B cells for surface expression of CD23 and MHC class II and found no effect of the cytoplasmic truncations (data not shown). However, peripheral B lymphocytes in Ig␣⌬C and Ig␤⌬C mice expressed higher levels of CD19 (Fig. 1 D) . Splenic B cells in Ig␣⌬C mice expressed normal levels of cell surface IgM. In contrast, the splenic B cells found in Ig␤⌬C mice resembled their bone marrow precursors and continued to express 10 times lower levels of surface IgM and 0.5 times lower levels of IgD than controls (Fig. 1 D) .
The scarce peripheral B cells in Ig␣⌬C mice produce specific antibody responses to T cell-dependent but not to T cell-independent antigens (25) . To determine whether Ig␤⌬C B cells can respond to antigens, we immunized mice with T cell-dependent (NP-CGG) and T cell-independent (NP-Ficoll) antigens and measured specific antibody responses by ELISA. Ig␤⌬C B cells mount a hapten specific immune response to NP-CGG with class switching to IgG, but do not appear to respond to NP-Ficoll. Consistent with the small number of peripheral B cells in the Ig-␤⌬C mice, anti-NP antibody titers were two orders of magnitude lower than controls (Fig. 4) . We conclude that like Ig␣⌬C B cells, Ig␤⌬C B cells respond to T cell-dependent but not T cell-independent antigens. Ca 2ϩ Flux. Ca 2ϩ flux responses are enhanced in immature B cells from Ig HEL transgenic, Ig␣⌬C mice (27) . This increase in the Ca 2ϩ response could be due to a unique negative regulatory role for Ig␣ in developing B cells or, alternatively, to a difference in Ca 2ϩ responses induced by Ig HEL transgene expression in the Ig␣⌬C background (27) . To determine whether altered responses to BCR crosslinking were Ig␣⌬C specific, we measured Ca 2ϩ flux in response to BCR cross-linking in immature Ig␤⌬C bone marrow cells. B cells expressing similar levels of surface IgM were compared by electronically gating on surface IgM expression after staining with an FabЈ anti-IgM. We found no measurable differences in Ca 2ϩ responses to anti-BCR cross-linking between immature Ig␤⌬C B cells and control immature B cells (Fig. 5) Fig. 6 A) . We conclude that B cell development cannot proceed beyond the pre-BI stage in the absence of the cytoplasmic domains of both Ig␣ and Ig␤.
Mixtures of B220 ϩ CD43 ϩ pro-and pre-B cells purified from Ig␤ Ϫ/Ϫ mice have fewer complete VDJ H genes than wild-type B220 ϩ CD43 ϩ IgM Ϫ pro-and pre-B cells (24) . This effect could be due to inefficient V to DJ H recombination in pre-BI cells lacking Ig␤, or to lack of positive selection and amplification of pre-BII cells with in-frame Ig H chains (24) . To determine whether the cytoplasmic domains of Ig␣ and Ig␤ are required for Ig H chain recombination and expression, we stained for intracellular Ig. Developing B cells in Ig␣⌬C/Ig␤⌬C, Ig␤ Ϫ/Ϫ , MT, recombination activating gene (RAG) Ϫ/Ϫ , and wild-type mice were compared after cell surface staining with anti-B220, anti-CD43, anti-CD25, and anti-IgM to separate pre-BI and pre-BII cell subpopulations, and intracellular staining for Ig to measure H chain expression. Consistent with previous reports, intracellular Ig levels in B220 ϩ CD43 ϩ IgM Ϫ mixtures of pre-BI and pre-BII cells were decreased in Ig␤ Ϫ/Ϫ mice compared with wild-type controls (Fig. 6 B) . Ig␣⌬C/Ig␤⌬C and MT mice resembled Ig␤ Ϫ/Ϫ mice in that their B220 ϩ CD43 ϩ cells also showed lower levels of intracellular Ig expression than controls. However, intracellular Ig levels in pre-BI cells in Ig␣⌬C/Ig␤⌬C mice were similar to Ig␤ Ϫ/Ϫ , MT, and wild-type controls (B220 ϩ CD43 ϩ IgM Ϫ CD25 Ϫ cells; Fig. 6  B) . Therefore, the decreased Ig expression in the developing B cells in these mutant strains is due to arrest at the pre-BI stage and lack of positive selection for B cells with an in-frame Ig H chain during pre-BII cell expansion. We conclude that the cytoplasmic domains of Ig␣ and Ig␤ are essential for B cell development past the pre-BI stage, and that Ig␣⌬C/Ig␤⌬C, Ig␤ Ϫ/Ϫ , and MT are all arrested at a similar stage in development. due to failure to activate a BCR-dependent checkpoint, it might also be due to aberrant expression of BCR components. For example, expression of Ig and Ig␣ in the absence of Ig␤ in Ig␤ Ϫ/Ϫ mice produces an incomplete receptor that is not transported to the cell surface and might be toxic for developing pre-B cells. Similarly, only very low levels of Ig␣-Ig␤ are expressed on the cell surface in the absence of mIg in RAG Ϫ/Ϫ B cells (45) . In contrast, the combination of Ig␣⌬C and Ig␤⌬C mutations produces surface BCRs that are simply unable to signal. Therefore, the finding that Ig␣⌬C/Ig␤⌬C B cells arrest at the pre-BI stage shows that the cytoplasmic domain of either Ig␣⌬C or Ig␤⌬C is essential for early B cell development, and that BCR signaling as opposed to assembly is required for later stages of B cell development.
Discussion
Ig␣ or Ig␤ Signaling Is Essential for
B Cell Development Differs in Ig␣⌬C and Ig␤⌬C Mice. Many aspects of B cell development are similar in Ig␣⌬C and Ig␤⌬C mice. For example, pre-B cell development and allelic exclusion are activated in both strains, and there are few peripheral B cells in either. However, the two strains differ in that B cells are lost throughout development in Ig-␣⌬C mice, whereas significant B cell loss is not apparent in Ig␤⌬C mice until the late stages of B cell maturation. Ig-␤⌬C B cell development is arrested before high level surface IgM expression and acquisition of surface IgD. Low surface IgM expression is not characteristic of Ig␣⌬C mice and appears to be specific for Ig␤⌬C, suggesting that the cytoplasmic domain of Ig␤ plays an important role in regulating surface BCR expression. Alternatively, the single Ig␣ molecule may interfere with receptor assembly or enhance receptor degradation in Ig␤⌬C mice. Failure to acquire high levels of surface IgM is not due to an intrinsic defect in BCR expression, as there is a broad spectrum of IgM expression in the selected B cells found in the spleen of Ig␤⌬C mice including B cells that express high levels of surface IgM. Indeed, the heterogeneity of BCR surface expression suggests that antibody specificity contributes to setting the level of BCR expression in Ig␤⌬C mice. We would like to speculate that decreased surface BCR expression is a consequence of altered BCR signaling in Ig␤⌬C B cells.
The differences in B cell development between Ig␣⌬C and Ig␤⌬C mice are reminiscent of the differences in signaling between Ig␣ and Ig␤ chimeras in transfected cell lines. B and T cell lines transfected with Ig␣ chimeras showed higher levels of signaling than those transfected with Ig␤ chimeras (6, 7, (10) (11) (12) (13) (14) . Furthermore, in some cell lines, chimeric receptors required both Ig␣ and Ig␤ cytoplasmic domains to trigger cell death (13) . However, the differences in the Ig␣⌬C and Ig␤⌬C mice were unexpected because transgenic mice that carry Ig-Ig␣ or IgIg␤ chimeric receptors showed equivalent function in early (8, 22) and late stages of development (23) . Furthermore, in both Ig-Ig␣ or Ig-Ig␤ transgenics, B cells developed fully and left the bone marrow whereas Ig␣⌬C and Ig␤⌬C mice show few mature B cells in the spleen (23) . Several differences between the chimeric antibody transgenics and Ig␣⌬C and Ig␤⌬C mice could account for these apparent discrepancies. First, the transgenic mice carried artificial receptors in which the tails of Ig␣ or Ig␤ were grafted onto heterologous transmembrane and external domains (8, 22, 23) . Second, the genes coding for the transgenic receptors were controlled by Ig regulatory elements in multicopy randomly integrated loci and therefore the regulation of expression was not that of endogenous Ig␣ and Ig␤. Finally, the transgenic receptors carried dimers of Ig␣ or Ig␤ tails instead of the normal monomers and therefore had twice as many signaling ITAMs as the BCRs in Ig␣⌬C and Ig␤⌬C mice.
Experiments performed on TCR CD3 proteins suggest that the ITAM-containing cytoplasmic domains of ␥, ⑀, ␦, and proteins are functionally equivalent and that multiple ITAMs merely amplify signal strength (15) (16) (17) (18) (19) (20) (21) . However, the TCR is a complex with 4 signaling proteins containing 10 ITAMs, and the role of individual ITAMs in T cell function has not been fully explored. In contrast to the TCR, the BCR has only two transducers, each with a single ITAM, and therefore differences between Ig␣⌬C and Ig␤⌬C mice cannot simply be due to a difference in the number of ITAMs (46) . These differences in signaling between Ig␣ and Ig␤ may be attributed to the two additional non-ITAM tyrosines in the cytoplasmic domain of Ig␣ (nos. 204 and 176; references 2 and 46). Neither of these tyrosine residues is known to be phosphorylated upon BCR cross-linking. Nevertheless, the sequence around tyrosine 204, YDQV, conforms to a consensus src homology 2 (SH2) docking site (47) , and the acidic residues surrounding tyrosine 176 resemble those found in the cytoplasmic domain of erythrocyte band 3 protein, a target of ptk72 (48) . Therefore, tyrosine 204 and 176 in Ig␣ may recruit a distinct set of SH2 domain-containing signaling proteins, or simply enhance signaling through Ig␣ by increasing the number of SH2 docking sites on Ig␣. Other differences between Ig␣ and Ig␤ that could account for the differences in signaling include higher levels of serine and threonine phosphorylation on Ig␤ (9) and nonconserved residues between the tyrosines in the ITAMs of Ig␣ and Ig␤ that appear to modulate src kinase binding (49) .
An additional distinction between Ig␣⌬C and Ig␤⌬C mice is that the Ig␣ tail truncation created by Torres et al. (25) (50, 51) . In the absence of these negative regulators, B cells are hyperresponsive to BCR cross-linking. Therefore, one explanation for the hyperreactive phenotype in Ig␣⌬C and Ig␤⌬C Ig HEL transgenic B cells might be that their BCRs are unable to recruit negative regulators of signal transduction such as SHP1 and lyn.
In contrast to Ig␤⌬C Ig HEL transgenic B cells, nontransgenic Ig␤⌬C B cells are indistinguishable from controls in Ca 2ϩ flux experiments. Thus, the hyperactive phenotype appears to be Ig transgene specific. The discrepancy between Ig␤⌬C Ig HEL transgenic B cells and nontransgenic Ig␤⌬C B cells could be due to partial compensation for abnormal B cell development in Ig␤⌬C mice by the Ig HEL transgene. Alternatively, the difference between transgenic and nontransgenic B cells could be due to artificially accelerated and altered B cell development in the transgenic mice.
A unique negative regulatory role for Ig␣ was suggested by experiments with Ig␣⌬C mice (26, 27) . However, Ig-␤⌬C Ig HEL transgenic B cells resemble Ig␣⌬C Ig HEL transgenic B cells in that they too were hyperresponsive compared with Ig HEL controls in Ca 2ϩ flux experiments. Thus, the absence of either Ig␣ or Ig␤ produces a hyperreactive Ig HEL transgenic B cell and this negative regulatory effect is not specific for Ig␣ or Ig␤.
Arrested B Cell Development in Ig␤⌬C Mice. Several mutations in signaling molecules and B cell coactivators have phenotypes similar to Ig␤⌬C. In humans, Btk mutation interferes with B cell development at several stages, beginning at the pre-B cell stage resulting in a near absence of peripheral B cells (X-linked agammaglobulinemia [52] [53] [54] ). In mice, Btk mutation results in a four-to fivefold decrease in the number of recent bone marrow emigrants. Although the number of mature B cells is near normal, T cell-independent responses are severely diminished in these mice (55) (56) (57) (58) . Phosphoinositide 3-kinase deficiency in mice resembles Btk mutation in that there are decreased numbers of mature peripheral B cells and decreased levels of serum Ig (59, 60) . Mouse mutations in B cell coreceptors CD22 (61, 62) , CD19 (63, 64) , the lyn kinase (65) , and the CD45 phosphatase (66) all interfere with B cell development at the immature to mature B cell transition, but these effects are more subtle and less specific than the block in B cell development seen in Ig␤⌬C mice.
Immature B cells are highly susceptible to deletion induced by BCR cross-linking, a feature which is likely to contribute to B cell tolerance by removing cells with selfreactive receptors (67, 68) . Our work shows that this checkpoint is regulated by Ig␣-Ig␤ and that Ig␤ plays a particularly important role in setting the threshold for B cell development beyond the immature B cell stage.
